Upgrade to SI Premium - Free Trial

Jefferies Downgrades Alnylam Pharmaceuticals (ALNY) to Hold

March 16, 2026 12:54 AM
Jefferies analyst Faisal Khurshid downgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from Buy to Hold with a price target of $330.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades